Prudential Financial’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.85M Sell
429,335
-159,975
-27% -$1.43M 0.01% 1057
2025
Q1
$4.42M Sell
589,310
-393,723
-40% -$2.95M 0.01% 891
2024
Q4
$7.39M Buy
983,033
+90,603
+10% +$681K 0.01% 719
2024
Q3
$6.78M Buy
892,430
+876,205
+5,400% +$6.66M 0.01% 847
2024
Q2
$100K Buy
16,225
+1,760
+12% +$10.9K ﹤0.01% 2545
2024
Q1
$73.5K Hold
14,465
﹤0.01% 2556
2023
Q4
$86.6K Buy
14,465
+460
+3% +$2.76K ﹤0.01% 2512
2023
Q3
$99.2K Hold
14,005
﹤0.01% 2447
2023
Q2
$98.6K Hold
14,005
﹤0.01% 2486
2023
Q1
$152K Sell
14,005
-55
-0.4% -$596 ﹤0.01% 2427
2022
Q4
$161K Sell
14,060
-225
-2% -$2.58K ﹤0.01% 2428
2022
Q3
$155K Buy
14,285
+230
+2% +$2.5K ﹤0.01% 2483
2022
Q2
$130K Hold
14,055
﹤0.01% 2507
2022
Q1
$228K Buy
14,055
+205
+1% +$3.33K ﹤0.01% 2481
2021
Q4
$192K Sell
13,850
-1,250
-8% -$17.3K ﹤0.01% 2551
2021
Q3
$217K Buy
15,100
+1,230
+9% +$17.7K ﹤0.01% 2450
2021
Q2
$219K Buy
13,870
+240
+2% +$3.79K ﹤0.01% 2427
2021
Q1
$139K Sell
13,630
-920
-6% -$9.38K ﹤0.01% 2428
2020
Q4
$108K Buy
14,550
+1,870
+15% +$13.9K ﹤0.01% 2392
2020
Q3
$43K Buy
12,680
+890
+8% +$3.02K ﹤0.01% 2392
2020
Q2
$56K Buy
11,790
+590
+5% +$2.8K ﹤0.01% 2357
2020
Q1
$22K Buy
11,200
+180
+2% +$354 ﹤0.01% 2322
2019
Q4
$38K Buy
+11,020
New +$38K ﹤0.01% 2404
2019
Q3
Sell
-10,610
Closed -$40K 2416
2019
Q2
$40K Buy
10,610
+140
+1% +$528 ﹤0.01% 2432
2019
Q1
$85K Hold
10,470
﹤0.01% 2384
2018
Q4
$84K Sell
10,470
-230
-2% -$1.85K ﹤0.01% 2314
2018
Q3
$82K Buy
+10,700
New +$82K ﹤0.01% 2387
2014
Q3
Sell
-13,200
Closed -$168K 2217
2014
Q2
$168K Buy
+13,200
New +$168K ﹤0.01% 2303